Table 2. Laboratory, histopathologic, and radiologic findings in patients at time of hospital admission for intensive rhino-sino-orbital and cerebral mucormycosis after undergoing treatment for COVID-19, India*.
| Characteristic | Result |
|---|---|
| Laboratory findings within 48 h of admission | |
| Hemoglobin level | 10.3 (9.3–11.7) |
| MCV, fL | 82.25 (77.75–86) |
| MCH, pg | 27.6 (26–29) |
| MCHC, g/dL |
32.4 (29.2–33.3) |
| Lymphocyte counts | |
| Total cells/mm3 | 8,470 (6,020–12,000) |
| Lymphocyte, % | 18.2 (11.9–24.7) |
| Distribution | |
| >10,000 cells/mm3 | 67 (38) |
|
<4,000 cells/mm3 |
15 (8) |
| Absolute neutrophil count | |
| <500 | 0 |
| 500–1,000 | 0 |
| 1,000–1,500 | 4 (2) |
| 1,500–8,000 | 114 (64) |
|
>8,000 |
60 (34) |
| Chemistry parameters | |
| AST >40 U/L | 17 (10) |
| ALT >40U/L | 34 (21) |
| Platelets, × 103/μL | 266.5 (204–336) |
| Serum creatinine, mg/dL | 1 (0.9–1.3) |
| Potassium, mEq/L | 3.54 (2.96–4.05) |
| Sodium, mEq/L | 136 (132–142) |
| Serum calcium, mg/dL |
8.65 (7.95–9.2) |
| Location(s) involved | |
| Nose and paranasal sinus | 171 (96) |
| Pterygopalatine fossa | 52 (29) |
| Orbital region | 86 (48) |
| Intracranial soft tissue | 22 (12) |
| Alveolar and palate soft tissue | 25 (14) |
*Values are no. (%) or median (IQR) except as indicated. ALT, alanine aminotransferase; ANC, absolute neutrophil count; AST, aspartate aminotransferase; COVID-19, coronavirus disease; IQR, interquartile range; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume.